02-101
Endothelial Cell Growth Supplement, 50mg
The Endothelial Cell Growth Supplement is designed for use as a cell culture media supplement. This cell growth supplement is available in a 50 mg format & has been optimized & validated for cell culture.
Sinonimo/i:
Primary Cell Culture Supplement
Autenticati per visualizzare i prezzi organizzativi e contrattuali.
Scegli un formato
Cambia visualizzazione
| Taglio della confezione | SKU | Disponibilità | Prezzo |
|---|---|---|---|
| 50 mg | Disponibile per la spedizione OGGIdaMerck S.p.A | 317,00 € |
Informazioni su questo articolo
UNSPSC Code:
12352207
NACRES:
NA.77
eCl@ss:
32160801
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutartiQuality Level
form
liquid
manufacturer/tradename
Millipore, Upstate®
technique(s)
cell culture | mammalian: suitable
input
sample type neural stem cell(s)
sample type epithelial cells
shipped in
dry ice
storage temp.
-10 to -25°C
General description
The Endothelial Cell Growth Supplement (ECGS) is designed for cell culture media supplement. This cell growth supplement ECGS is a mitogenic and is applicable for culturing mammalian, human endothelial cells, avian, smooth muscle cells, melanocytes, keratinocytes, and hybridomas either under reduced or serum-free conditions. It acts as a substitute for feeder layers in fastidious cell cultures.
Application
Endothelial Cell Growth Supplement, 50mg has been used to culture human umbilical vein endothelial cells (HUVECs).[1]
Physical form
lyophilized from sterile water containing trace amounts of NaCl and streptomycin sulfate
Preparation Note
Lyophilized: 2 years at 4°C; rehydrated: 3 months at -20°C.
Analysis Note
routinely evaluated in a 5 day growth assay of fetal bovine heart endothelial cells
Legal Information
UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
1 of 1
Questo articolo | |||
|---|---|---|---|
| technique(s) cell culture | mammalian: suitable | technique(s) cell culture | mammalian: suitable | technique(s) - | technique(s) cell culture | mammalian: suitable |
| form liquid | form liquid | form liquid | form liquid |
| storage temp. -10 to -25°C | storage temp. -10 to -25°C | storage temp. −20°C | storage temp. −20°C |
| shipped in dry ice | shipped in dry ice | shipped in dry ice | shipped in dry ice |
| Quality Level 100 | Quality Level 100 | Quality Level 100 | Quality Level - |
| input sample type neural stem cell(s) | input sample type neural stem cell(s) | input - | input - |
Classe di stoccaggio
11 - Combustible Solids
wgk
WGK 2
Certificati d'analisi (COA)
Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.
N A Lanson et al.
Nucleic acids research, 28(15), 2882-2892 (2000-07-25)
To investigate molecular controls of cardiomyocyte proliferation, we utilized cardiomyocytes induced to proliferate indefinitely by SV40 large T antigen (T-ag). In the T-ag-immortalized AT-1, AT-2 and HL-1 cardiomyocytes, normal cellular proteins associating with T-ag and p53 were identified, isolated and
A T Kovala et al.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 14(15), 2486-2494 (2000-12-02)
The definition of signaling pathways in endothelial cells has been hampered by the difficulty of transiently transfecting these cells with high efficiency. This investigation was undertaken to develop an efficient technique for the transfection of endothelial cells for functional analyses.
S Strömblad et al.
The Journal of clinical investigation, 98(2), 426-433 (1996-07-15)
Induction of p53 activity in cells undergoing DNA synthesis represents a molecular conflict that can lead to apoptosis. During angiogenesis, proliferative endothelial cells become apoptotic in response to antagonists of integrin alphavbeta3 and this leads to the regression of angiogenic
Numero articolo commerciale globale
| SKU | GTIN |
|---|---|
| 02-101 | 04053252668890 |